Free Trial

Leerink Partnrs Reduces Earnings Estimates for Ardent Health

Ardent Health logo with Medical background

Ardent Health, Inc. (NYSE:ARDT - Free Report) - Research analysts at Leerink Partnrs lowered their Q2 2025 EPS estimates for shares of Ardent Health in a report released on Monday, June 23rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $0.22 per share for the quarter, down from their previous forecast of $0.59. The consensus estimate for Ardent Health's current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health's Q3 2025 earnings at $0.81 EPS.

Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. Ardent Health had a net margin of 3.73% and a return on equity of 16.07%.

Several other research analysts also recently weighed in on ARDT. Stephens reissued an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a research report on Tuesday, May 20th. Royal Bank Of Canada reissued an "outperform" rating and issued a $21.00 target price on shares of Ardent Health in a research report on Thursday, May 15th. Mizuho dropped their target price on shares of Ardent Health from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, Guggenheim lifted their target price on shares of Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of "Buy" and an average target price of $20.67.

Get Our Latest Report on Ardent Health

Ardent Health Trading Up 2.9%

Shares of Ardent Health stock traded up $0.38 during trading on Thursday, hitting $13.69. The stock had a trading volume of 827,810 shares, compared to its average volume of 384,125. The stock has a 50 day simple moving average of $13.75 and a 200 day simple moving average of $14.24. The company has a market capitalization of $1.96 billion and a PE ratio of 8.40. The company has a quick ratio of 1.98, a current ratio of 2.12 and a debt-to-equity ratio of 0.70. Ardent Health has a 1 year low of $11.31 and a 1 year high of $20.72.

Institutional Trading of Ardent Health

Institutional investors have recently added to or reduced their stakes in the business. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Ardent Health in the fourth quarter valued at approximately $27,000. US Bancorp DE acquired a new stake in Ardent Health in the fourth quarter valued at approximately $31,000. Morse Asset Management Inc acquired a new stake in Ardent Health in the first quarter valued at approximately $36,000. New York State Common Retirement Fund acquired a new stake in Ardent Health in the fourth quarter valued at approximately $48,000. Finally, Deutsche Bank AG lifted its stake in Ardent Health by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after acquiring an additional 2,654 shares during the last quarter.

About Ardent Health

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Recommended Stories

Earnings History and Estimates for Ardent Health (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Right Now?

Before you consider Ardent Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.

While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines